Symbiosis International University

US-based Airlinq Inc., appoints Vangipuram Kishore as Global COO

Retrieved on: 
Thursday, September 14, 2023

Kishore joins Airlinq's leadership team and will oversee key functions including product management and engineering, solution delivery, and managed services.

Key Points: 
  • Kishore joins Airlinq's leadership team and will oversee key functions including product management and engineering, solution delivery, and managed services.
  • Kishore joins Airlinq from Mobileum, a leading provider of analytics solutions for the Telecom industry, where he held several roles across his over two-decade stint.
  • Most recently, prior to joining Airlinq, he led the global service delivery and customer support functions for their global customer base.
  • Kishore brings his extensive experience in technology, product planning, service operations, and finance to Airlinq to execute the company's strategic growth plan and drive greater business performance.

Kellton expands its Digital Practice leadership team with new hires in Digital Engineering, IoT Platforms, Products and Strategic Alliances

Retrieved on: 
Wednesday, April 26, 2023

Gaurav joins Kellton as VP - Products & Strategic Alliances, while Rajat joins as AVP - Digital &  IoT Platforms, and Ajay joins as Director - Software Engineering.

Key Points: 
  • Gaurav joins Kellton as VP - Products & Strategic Alliances, while Rajat joins as AVP - Digital &  IoT Platforms, and Ajay joins as Director - Software Engineering.
  • Prior to joining Kellton, Rajat was part of the strategy team at Digital Transformation Solutions Division of Harman (A Samsung Company).
  • At Kellton, Rajat will lead the Strategy, P&L, and growth of the Digital & IoT Platforms, Products, and Solutions.
  • "Kellton is making significant investments in Digital transformation, software engineering, IoT platforms, products & strategic Alliances.

BARK Welcomes Aarti Sharma as Chief People Officer

Retrieved on: 
Monday, November 14, 2022

BARK, Inc. (BARK or the Company) (NYSE: BARK), a leading global omnichannel brand with a mission to make all dogs happy, today announced the appointment of Aarti Sharma as Chief People Officer (CPO), effective November 7, 2022.

Key Points: 
  • BARK, Inc. (BARK or the Company) (NYSE: BARK), a leading global omnichannel brand with a mission to make all dogs happy, today announced the appointment of Aarti Sharma as Chief People Officer (CPO), effective November 7, 2022.
  • Most recently, Sharma served nine years as the Global Head of Human Resources at Cambium Networks where she built the HR infrastructure and tripled the organizations size.
  • Aarti is a fantastic addition to the team, and she brings valuable experience scaling high-growth technology companies, said Matt Meeker, Co-Founder and Chief Executive Officer of BARK.
  • Having just been named in Newsweeks Top 100 Most Loved Workplaces in America, it is clear that BARK is highly focused not just on the happiness of all dogs, but also all of its passionate employees, said Aarti Sharma, Chief People Officer of BARK.

Atos and Huma support Symbiosis Hospital in Pune to expand care capacity by up to 60% with new remote patient app

Retrieved on: 
Wednesday, December 1, 2021

This 'hospital at home' will allow the SUHRC to expand its capacity by around 40-60%.

Key Points: 
  • This 'hospital at home' will allow the SUHRC to expand its capacity by around 40-60%.
  • The 'hospital at home' system, delivered by Atos and built by Huma, is based on Huma's award-winning1 remote patient monitoring system that has already been used across England and Germany.
  • Clinicians can manage multiple patients, and with the available inputs can conduct consultations and care for their patients remotely.
  • "This symbiotic industry-academia partnership will help us deploy technology to provide healthcare services to patients in and around Pune.

Atos and Huma support Symbiosis Hospital in Pune to expand care capacity by up to 60% with new remote patient app

Retrieved on: 
Wednesday, December 1, 2021

This 'hospital at home' will allow the SUHRC to expand its capacity by around 40-60%.

Key Points: 
  • This 'hospital at home' will allow the SUHRC to expand its capacity by around 40-60%.
  • The 'hospital at home' system, delivered by Atos and built by Huma, is based on Huma's award-winning1 remote patient monitoring system that has already been used across England and Germany.
  • Clinicians can manage multiple patients, and with the available inputs can conduct consultations and care for their patients remotely.
  • "This symbiotic industry-academia partnership will help us deploy technology to provide healthcare services to patients in and around Pune.

SiTime Reports Second Quarter 2021 Financial Results

Retrieved on: 
Wednesday, August 4, 2021

SANTA CLARA, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) -- SiTime Corporation, (Nasdaq: SITM), a market leader in MEMS timing, today announced financial results for the second quarter ended June 30, 2021.

Key Points: 
  • SANTA CLARA, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) -- SiTime Corporation, (Nasdaq: SITM), a market leader in MEMS timing, today announced financial results for the second quarter ended June 30, 2021.
  • Net revenue in the second quarter of 2021 was $44.5 million, a 107.2% increase from the $21.5 million in the second quarter of 2020 and a 25.2% increase from the $35.5 million in the first quarter of 2021.
  • SiTime believes that the presentation of non-GAAP financial measures provides important supplemental information to management and investors regarding financial and business trends relating to SiTimes financial condition and results of operations.
  • SiTime will broadcast its second quarter of 2021 financial results conference call today, August 4, 2021, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time), which can be accessed by calling +1-844-467-7657 and using conference ID 9949706.

Stabilization measures taken

Retrieved on: 
Tuesday, October 27, 2020

56/2020 dated September 29, 2020 regarding beginning of the stabilization period following the global offering (the Global Offering), consisting of an initial public offering of American Depositary Shares (the ADSs), each such ADS representing one ordinary share (the Ordinary Shares), in the United States (the "U.S. Offering"), and a concurrent private placement of Ordinary Shares in Europe (the European Private Placement), Orphazyme A/S ("Orphazyme") has received notification from BofA Securities, Inc., who is acting as stabilizing manager in the Global Offering, that the stabilization measures set out in the attached notification have been taken.

Key Points: 
  • 56/2020 dated September 29, 2020 regarding beginning of the stabilization period following the global offering (the Global Offering), consisting of an initial public offering of American Depositary Shares (the ADSs), each such ADS representing one ordinary share (the Ordinary Shares), in the United States (the "U.S. Offering"), and a concurrent private placement of Ordinary Shares in Europe (the European Private Placement), Orphazyme A/S ("Orphazyme") has received notification from BofA Securities, Inc., who is acting as stabilizing manager in the Global Offering, that the stabilization measures set out in the attached notification have been taken.
  • Orphazyme is a late-stage biopharmaceutical company pioneering the Heat-Shock Protein response for the treatment of neurodegenerative orphan diseases.
  • Arimoclomol has received fast-track designation (FTD) from the U.S. Food and Drug Administration (FDA) for NPC, sIBM and ALS.
  • In addition, arimoclomol has received breakthrough therapy designation (BTD) and rare-pediatric disease designation (RPDD) from the FDA for NPC.